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Abstract: 
Objective: To determine the effectiveness of low dose tamsulosin as a medical expulsive therapy in patients with 
lower ureteric stones.  
Patients and Methods: The six months randomized control trial was conducted on all patients with either gender, 
age range 30-60 years and stone size 4-10 mm in the lower 1/3rd of the ureter determined on ultrasound at tertiary 
care hospital. Group A patients was offered low dose tamsulosin (0.2 mg) one tablet daily in the morning for a 
maximum of 4 weeks and group B served as control. The final outcome was measured at the end of 4th week of 
treatment. Patients were instructed to note the time and the date of expulsion of stone. Absence of echoic shadows 
on lower 1/3rd of ureteric line on ultrasound was taken as effectiveness (expulsion of stone). 
Results: In control group mean age was 45.52 ±6.70 years whereas in low dose Tamsulin mean age was 46.72 
±6.73 years. Frequency of male was higher in both control and low dose Tamsulin group, i.e. 39 (78%) and 21 
(42%) respectively. In control group effectiveness was found 3 (6%) patients whereas in low dose Tamsulin group 
effectiveness was found in 47 (94%).  
Conclusion: In our study the effectiveness of low dose tamsulosin as a medical expulsive therapy in patients with 
lower ureteric stones was higher as compared to control. 
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INTRODUCTION:  
Urolithiasis is an ancient disease with global 
distribution and has perplexed human beings and 
physicians for many centuries. Pakistan is situated in 
the middle of Afro-Asian stone belt, a high region of 
stone incidence. [1] Treatments for ureteric stones 
traditionally include watchful waiting, extracorporeal 
shock wave lithotripsy, ureteroscopy and open 
ureterolithotomy.  Minimally invasive techniques, 
such as shock wave lithotripsy and endourology, are 
now being used more frequently. Even minimally 
invasive surgery, however, is not free of 
complications and the cost is high.[2] Stone size and 
location are the main factors that can influence their 
passage; a stone smaller than 4 mm is usually passed 
after conservative treatment. [2] The human ureter  
contains  a high number of alpha adrenergic 
receptors, especially α1d -receptors at the lower part 
of the ureter. [3,4] Tamsulosin is  a combined alpha 
selective adrenergic antagonist  that is an alternative 
to other  medications,  such as calcium channel  
blockers,  corticosteroids, and analgesic and anti-
inflammatory drugs, for the treatment  of  distal  
ureteric stones. [5-7]The standard dose of tamsulosin 
for the treatment of distal uretic stones is 0.4 mg/day; 
many reports from Asian countries have confirmed 
that low-dose tamsulosin (0.2 mg/day) is effective in 
the treatment of benign prostatic hyperplasia (BPH). 
[5-7]There are few published clinical studies dealing 
with low-dose tamsulosin for medical expulsive 
therapy for ureteral stones. [8,9] In a randomized 
controlled trial (RCT) the ureteral stones expulsion 
rate was 4%, 40% and 68% in control, low dose 
(0.2mg) and standard dose (0.4 mg) tamsulosin 
groups respectively. [10] In another RCT The stone 
expulsion rate was signiﬁcantly higher in low dose 
tamsulosin group than in control group (77% vs 
50%,P=0.002). No signiﬁcant differences were noted 
in the stone expulsion time and analgesic use 
between the groups. [11] There was a validity issue 
in the above mentioned studies as the sample sizes 
were and hence the results cannot be generalized [10-
11]. Furthermore no local data is available on this 
topic locally and there is dearth of literature 
internationally as well. Therefore the present study 
was designed with proper calculation of sample size 
to assess the effectiveness of low dose tamsulosin in 
relation to age, so that if founds to be effective then 
the same could be used in future with confidence in 
patients with lower ureteric stones. 
 
PATIENTS AND METHODS:  
The six months randomized controlled trial was 
conducted for the determination of the demographical 
profile and effectiveness of low dose tamsulosin as a 
medical expulsive therapy in patients with lower 
ureteric stones at tertiary care hospital. The lower 
ureteric stones were considered as presence of echoic 
shadows on lower 1/3rd of ureteric line on ultrasound 
was taken as lower ureteric stones while the 
effectiveness was labeled when no stone in the lower 
1/3rd of the ureter at the end of 4th week of treatment, 
confirmed on ultrasound was taken as effectiveness 
positive. The inclusion criteria were the patients with 
stone size 4-10 mm determined on ultrasound, 
presence of stone in the lower 1/3rd of the ureter 
either gender and age range 30-60 years while the 
exclusion criteria were urinary tract infection, 
multiple stones, pregnancy, severe hydronephrosis, 
hypotension, ureteral stricture  and current use of 
calcium antagonists or alpha adrenergic blockers. To 
make two groups random allocation was done by a 
third person not involved in the study by asking 
patients to pick one sealed, opaque envelop bearing a 
card in it of group A and B. Group A patients was 
offered low dose tamsulosin (0.2 mg) one tablet daily 
in the morning for a maximum of 4 weeks and group 
B served as control. All patients were prescribed 50 
mg diclofenac suppository on demand for pain relief.  
Patients were further advised to take minimum 2 
liters of water daily. The patients were followed up 
on weekly basis along with X-ray KUB and 
ultrasonography. The final outcome was measured at 
the end of 4th week of treatment. Patients were 
instructed to note the time and the date of expulsion 
of stone. Absence of echoic shadows on lower 1/3rd 
of ureteric line on ultrasound was taken as 
effectiveness (expulsion of stone). The status of stone 
expulsion in terms of effectiveness and the 
demographics like age, gender, size of stone and time 
taken for stone expulsion was noted and entered in 
the questionnaire attached as annexure. Statistical 
Package for Social Sciences (SPSS) version 17was 
used for data entry and analysis. Frequency and 
percentages was calculated for gender and 
effectiveness (stone expulsion). 
 
RESULTS:  
Mean age of the patients in control group was 45.52 
±6.70 years whereas mean age of the patients in low 
dose Tamsulosin was 46.72 ±6.73 years. (Table 1) 
There were more male in both control and low dose 
Tamsulosin group, i.e. 39 (78%) and 21 (42%) 
respectively.(Figure 1) Mean stone size of the 
patients in control group was 6.16 ±1.20mm whereas 
mean stone size of the patient in low dose Tamsulin 
was 6.52 ±1.19mm. The results are presented in 
Table 1-4 and figure 1.  
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TABLE 1: AGE OF THE PATIENTS n=100 
   SD= Standard Deviation 
TABLE 2: COMPARISON OF EFFECTIVENESS IN BOTH GROUPS n=100 
Effectiveness 
Group 
Total 
p-value 
 
Control Tamsulosin 
Yes 3 (6) 19 (38) 22 (22) 
0.001 No 47 (94) 31 (62) 78 (78) 
Total 50 (100) 50 (100) 100 (100) 
n (%) 
TABLE 3: ≤45 YEARS AGE GROUPCOMPARISON OF EFFECTIVENESS IN BOTH GROUPS n=100 
Effectiveness 
Group 
Total 
p-value 
 Control Tamsulosin 
Yes 3 (7.5) 14 (37.8) 17 (22.1) 
0.001 No 37 (92.5) 23 (62.2) 60 (77.9) 
Total 40 (100) 37 (100) 77 (100) 
n (%) 
TABLE 4: >45 YEARS AGE GROUPCOMPARISON OF EFFECTIVENESS IN BOTH GROUPS n=100 
Effectiveness 
Group 
Total 
p-value 
 Control Tamsulosin 
Yes 0 (0) 5 (38.5) 5 (21.7) 
.027 No 10 (100) 8 (61.5) 18 (78) 
Total 10 (100) 13 (100) 23 (100) 
n (%) 
 
 
AGE OF THE 
PATIENTS    (in 
years) 
Control Tamsulosin 
Mean 
Difference 
P-value 95% C.I 
Mean ±SD Mean ±SD 
45.52 ±6.70 46.72 ±6.73 -1.2 0.374 -3.8 to 1.46 
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FIG,1: GENDER DISTRIBUTION 
 
DISCUSSION:  
There are few published clinical studies dealing with 
low-dose tamsulosin for medical expulsive therapy 
for ureteral stones [8,9]. In a randomized controlled 
trial (RCT) the ureteral stones expulsion rate was 4%, 
40% and 68% in control, low dose (0.2mg) and 
standard dose (0.4 mg) tamsulosin groups 
respectively [10].  In another RCT the stone 
expulsion rate was significantly higher in low dose 
tamsulosin group than in control group (77% vs 50%, 
P=0.002). No significant differences were noted in 
the stone expulsion time and analgesic use between 
the groups [11]. Improved detection of stones, 
increasing lifespan, and dietary changes may be 
related to the increased prevalence of stone disease 
[12]. A meta-analysis by the American Urological 
Association (AUA) Guidelines Panel determined that 
ureteral stones with a diameter of less than 5 mm will 
pass in up to 98% of cases. [14] For stones with 
diameters greater than 7 mm, the overall chance of 
spontaneous passage is low. [15, 16] Overall passage 
rate is 25% for proximal, 45% for middle and 75% 
for distal ureteric stones. [14] In this study, Overall 
effectiveness was found in 22 (22%) of the patients. 
In control group effectiveness was found 3 (6%) 
patients whereas in low dose Tamsulin group 
effectiveness was found in 47 (94%). Chi-square test 
was applied and statistically sufficient evidence of 
significant relationship was observed as p-value was 
found to be less than level of significance (p-value 
<0.01). 
 
CONCLUSION:  
The effectiveness of low dose tamsulosin as a 
medical expulsive therapy in patients with lower 
ureteric stones was higher as compared to control. 
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